UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus

Ghosn, J; Bayan, T; Meixenberger, K; Tran, L; Frange, P; Monforte, ADA; Zangerle, R; ... Scott, M; + view all (2017) CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus. Journal of Antimicrobial Chemotherapy , 72 (10) pp. 2862-2868. 10.1093/jac/dkx247. Green open access

[thumbnail of Phillips_JG-Tropisme-CASCADE-REVISED-17062017.pdf]
Preview
Text
Phillips_JG-Tropisme-CASCADE-REVISED-17062017.pdf - Accepted Version

Download (558kB) | Preview

Abstract

BACKGROUND: THe natural clinical and immunological courses following HIV seroconversion with CXCR4-tropic or dual-mixed (X4/DM) viruses are controversial. We compared spontaneous immunological outcome in patients harbouring an X4/DM virus at the time of seroconversion with those harbouring a CCR5-tropic (R5) virus. METHODS: Data were included from patients participating in CASCADE, a large cohort collaboration of HIV seroconverters, with ≥ 2 years of follow-up since seroconversion. The HIV envelope gene was sequenced from frozen plasma samples collected at enrolment, and HIV tropismwas determined using Geno 2Pheno (false-positive rate 10%). The spontaneous CD4 T cell evolution was compared by modelling CD4 kinetics using linear mixed-effects models with random intercept and random slope. RESULTS: A total of 1387 patients were eligible. Median time between seroconversion and enrolment was 1month (range 0-3). At enrolment, 202 of 1387 (15%) harboured an X4/DM-tropic virus. CD4 decrease slopes were not significantly different according to HIV-1 tropism during the first 30months after seroconversion. No marked change in these results was found after adjusting for age, year of seroconversion and baseline HIV viral load. Time to antiretroviral treatment initiation was not statistically different between patients harbouring an R5 (20.76months) and those harbouring an X4/DM-tropic virus (22.86months, logrank test P"0.32). CONCLUSIONS: In this large cohort collaboration, 15% of the patients harboured an X4/DM virus close to HIV seroconversion. Patients harbouring X4/DM-tropic viruses close to seroconversion did not have an increased risk of disease progression, estimated by the decline in CD4 T cell count or time to combined ART initiation.

Type: Article
Title: CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/jac/dkx247
Publisher version: https://doi.org/10.1093/jac/dkx247
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: hiv, disease progression, follow-up, hiv seropositivity, hiv-1, plasma, chemokine (c-c motif) receptor 5, cxcr4 receptors, t-lymphocyte, tropism, viral load result, viruses, anti-retroviral agents, seroconversion
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health
URI: https://discovery.ucl.ac.uk/id/eprint/10042618
Downloads since deposit
88Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item